Lilly 3977 40 mg Pill - gray capsule/oblong, 18mm

Generic Name: selpercatinib

Pill with imprint Lilly 3977 40 mg is Gray, Capsule/Oblong and has been identified as Retevmo 40 mg. It is supplied by Eli Lilly and Company.

Retevmo is used in the treatment of Thyroid Cancer; Non Small Cell Lung Cancer; Solid Tumors and belongs to the drug class multikinase inhibitors. Retevmo 40 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Lilly 3977 40 mg

Retevmo

Generic Name

selpercatinib

Imprint

Lilly 3977 40 mg

Strength

40 mg

Color

Gray

Size

18.00 mm

Shape

Capsule/Oblong

Availability

Prescription only

Drug Class

Multikinase inhibitors

CSA Schedule

Not a controlled drug

Labeler / Supplier

Eli Lilly and Company

National Drug Code (NDC)

00002-3977

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer